Journals / Kriz Dergisi / 2018 / Cilt: 26 - Sayı: 2

BIPOLAR DISORDER IN ADOLESCENTS: TREATMENT STRATEGIES AND COMORBIDITIES

ERGENLERDE BİPOLAR BOZUKLUK: TEDAVİ STRATEJİLERİ VE EŞ TANILAR

Pages
0–0
Publication Date
2018-08-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The difficulty of diagnosing in adolescents, the adolescents that use pharmacological treatment being the ones that have more severe symptoms and comorbidities may be the reason for these results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Bipolar disorder is an important cause of morbidity and mortality because of its consequences such as cognitive/functional disorders and suicide attempts.
📊
Key Findings & Data:Since recognition and treatment of this disorder is crucial in adulthood, we aim to investigate the comorbidities and treatment strategies of bipolar disorder in Adulthood Unit in our clinic.
💡
Conclusion & Impact:The difficulty of diagnosing in adolescents, the adolescents that use pharmacological treatment being the ones that have more severe symptoms and comorbidities may be the reason for these results.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:ergen · bipolar bozukluk · eştanı

Abstract

Introduction: Bipolar disorder is an important cause of morbidity and mortality because of its consequences such as cognitive/functional disorders and suicide attempts. Most of the cases that diagnosed as bipolar disorder in adulthood are known to have the symptoms since adolescence. Since recognition and treatment of this disorder is crucial in adulthood, we aim to investigate the comorbidities and treatment strategies of bipolar disorder in Adulthood Unit in our clinic. Method: The folders of the patients who admitted the Ankara University Department of Psychiatry Adulthood Outpatient Clinic between June 2016-May 2017 and diagnosed as bipolar disorder are searched retrospectively. Comorbidities and treatments of these patients are investigated, the relations between this data are analyzed with statistical analyses. Results: 47 cases; 31 female (66%, mean age: 19,48), 16 male (34%, mean age: 18,94) are included in the study. The rate of comorbidity is 59,6%, the most common comorbidities are; attention deficit and hyperactivity disorder, mental retardation and obsessive-compulsive disorder. 87,2% of the cases use mood stabilizer, 93,6% use antipsychotic drugs and 19,1% use antidepressants. Multiple drug use is significantly greater in the cases with comorbidities. Discussion: In our sample with adulthood bipolar disorder, the rates of comorbidity and multiple drug use are high. The difficulty of diagnosing in adolescents, the adolescents that use pharmacological treatment being the ones that have more severe symptoms and comorbidities may be the reason for these results.

Özet

Giriş: Bipolar bozukluk, genç nüfusta bilişsel ve fonksiyonel bozukluklar, intihar girişimleri gibi sonuçları nedeniyle önemli bir morbidite ve mortalite nedenidir. Erişkinlikte bipolar bozukluk tanısı konulan olguların genellikle ilk olarak ergenlik döneminde şikayetlerinin başladığı bilinmektedir. Ergen yaş grubunda tanınması ve tedavisi önemli olan bu bozukluğun kliniğimiz Ergen Ünitesinde eş tanı ve tedavi stratejilerini incelemeyi amaçladık. Yöntem: Ankara Üniversitesi Tıp Fakültesi Ruh Sağlığı ve Hastalıkları Anabilim Dalı Ergen Ünitesi polikliniğine Haziran 2016-Mayıs 2017 tarihleri arasında ayaktan başvuran bipolar bozukluk tanılı olguların dosyaları retrospektif olarak taranmıştır. Olguların eştanıları ve aldıkları tedaviler gözden geçirilmiş, veriler arasındaki ilişkiler istatistiksel analizler ile değerlendirilmiştir. Sonuçlar: 31 kadın (%66, yaş ort: 19,48), 16 erkek (%34, yaş ort: 18,94) olmak üzere 47 olgu çalışmaya dahil edilmiştir. Eş tanı sıklığı %59,6 olup, en sık eş tanılar; dikkat eksikliği ve hiperaktivite bozukluğu, mental retardasyon ve obsesif kompulsif bozukluktur. Olguların %87,2'si duygudurum düzenleyici, % 93,6'sı antipsikotik, %19,1’i antidepresan kullanmaktadır. Eş tanı varlığında çoklu ilaç kullanımının anlamlı derecede fazla olduğu saptanmıştır. Tartışma: Ergen bipolar bozuklukta örneklemimizde eş tanı ve çoklu ilaç kullanım oranlarının yüksek olduğu görülmektedir. Ergenlerde tanının zorluğu, ilaç tedavisi alan ergenlerin genellikle şiddetli belirtileri ve eşlik eden bozukluklarının olması bu durum üzerinde etkili olabilir.

🔖

Cite This Article

ERTAN, E. A., ÇETİNKAYA, B. Ö. (2018). BIPOLAR DISORDER IN ADOLESCENTS: TREATMENT STRATEGIES AND COMORBIDITIES. Kriz Dergisi, Cilt: 26 - Sayı: 2, 0–0. https://ajindex.com/articles/247531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Birmaher, B. (2013). Bipolar disorder in children and adolescents. Child and Adolescent Mental Health, 18(3), 140–148.
  2. Birmaher, B., Axelson, D., Goldstein, B., Strober, M., Gill, M. K., Hunt, J., … Kim, E. (2009). Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. American Journal of Psychiatry, 166(7), 795–804.
  3. Carlson, G. A., Loney, J., Salisbury, H., Kramer, J. R., & Arthur, C. (2000). Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. Journal of Child and Adolescent Psychopharmacology, 10(3), 175–184.
  4. Delbello, M. P., Schwiers, M. L., Rosenberg, H. L., & Strakowski, S. M. (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child & Adolescent Psychiatry, 41(10), 1216–1223.
  5. Diler, R. S., Uguz, S., Seydaoglu, G., Erol, N., & Avci, A. (2007). Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder. Bipolar Disord, 9(3), 243–251.
  6. Duffy, A. (2009). The early course of bipolar disorder in youth at familial risk. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 18(3), 200. Evans-Lacko, S. E., Zeber, J. E., Gonzalez, J. M., & Olvera, R. L. (2009). Medical comorbidity among youth diagnosed with bipolar disorder in the United States. Journal of Clinical Psychiatry, 70(10), 1461–1466. Frías, Á., Palma, C., & Farriols, N. (2015). Comorbidity in pediatric bipolar disorder: prevalence, clinical impact, etiology and treatment. Journal of Affective Disorders, 174, 378–389.
  7. Galanter, C. A., Carlson, G. A., Jensen, P. S., Greenhill, L. L., Davies, M., Li, W., … March, J. S. (2003). Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. Journal of Child and Adolescent Psychopharmacology, 13(2), 123–136.
  8. Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016). Bipolar disorder. The Lancet, 387(10027), 1561–1572.
  9. Kafantaris, V., Coletti, D. J., Dicker, R., Padula, G., & Kane, J. M. (2001). Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. Journal of the American Academy of Child & Adolescent Psychiatry, 40(12), 1448–1456.
  10. Khazanov, G. K., Cui, L., Merikangas, K. R., &